124 results
DEFA14A
DTIL
Precision Biosciences Inc
25 Apr 24
Additional proxy soliciting materials
4:34pm
Materials.
Soliciting Material under § 240.14a-12.
Precision BioSciences, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
8-K
DTIL
Precision Biosciences Inc
16 Apr 24
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
4:47pm
agreements, to assign and transfer to the Company all right, title and interest in and to all materials, preclinical and clinical data, safety data and all
8-K
EX-99.1
DTIL
Precision Biosciences Inc
16 Apr 24
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
4:47pm
is (800) 715-9871 and the conference ID number for the call is 2110172. Participants may access the live webcast, and accompanying presentation materials
8-K
EX-1.1
ycbk ykxl
1 Mar 24
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
8:00am
8-K
EX-10.2
zse3rhbga5
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.3
42pqljoiva0k
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.4
850fr8
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
EX-10.1
80qf1u 696
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
DEFA14A
woi0 7gj3k9da
12 Jan 24
Additional proxy soliciting materials
8:00am
8-K
3dpew7w8
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
8-K
EX-3.1
kaz wks4x
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
DEFA14A
oo00m4tqm0xq9f9z8j
4 Dec 23
Additional proxy soliciting materials
4:30pm
PRE 14A
o6kkm
22 Nov 23
Preliminary proxy
4:30pm
8-K/A
EX-2.1
cbd6 spqau
21 Aug 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
7:00am